Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Neuromuscular Disease|June 5, 2009
Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and reviewRobert P Nelson, Robert M Pascuzzi, Kenneth Kessler, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 8, 2009
A phase II trial of talampanel in subjects with amyotrophic lateral sclerosisRobert M Pascuzzi, Jeremy Shefner, Amy S Chappell, et al.
Neurology|January 9, 2013
Association between performance on Neurology In-Training and Certification ExaminationsDorthea Juul, Frederick G Flynn, Laurie Gutmann, et al.
Scientific Reports|November 21, 2015
Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral SclerosisChristine V Fontanilla, Huiying Gu, Qingpeng Liu, et al.
European Journal of Neurology|August 4, 2025
Improvement in Patient-Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PROHenry J Kaminski, Carlo Antozzi, Ali A Habib, et al.
The New England Journal of Medicine|June 21, 2008
Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1William J Groh, Miriam R Groh, Chandan Saha, et al.
Therapeutic Advances in Neurological Disorders|September 19, 2024
Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG studyAli A Habib, Sabrina Sacconi, Giovanni Antonini, et al.
Muscle & Nerve|December 28, 2017
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myastheniaDonald B Sanders, Vern C Juel, Yadollah Harati, et al.
Muscle & Nerve|November 7, 2024
Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trialVera Bril, Tomasz Berkowicz, Andrzej Szczudlik, et al.
Neurology|October 21, 2022
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia GravisVera Bril, Andrzej Szczudlik, Antanas Vaitkus, et al.
Pageof 4